HIF1A and breast cancer: Noteworthy is the effect of sorafenib, which, in combination with γ-irradiation, suppressed the HIF-1 expression and killed CSCs in breast cancer cells (MDA-MB-231 and MCF-7 lines) subjected to hypoxia [96].